“VTT”-Domain Proteins VMP1 and TMEM41B Function in Lipid Homeostasis Globally and Locally as ER Scramblases

TMEM41B and VMP1 as ER-Resident Lipid Scramblases

In a pair of recent publications, our groups as well as Yang and colleagues established TMEM41B and VMP1 as lipid scramblases using a series of in vitro reconstitution assays (Ghanbarpour et al., 2021; Li et al., 2021). Either protein alone, or in combination, was able to redistribute a variety of fluorescently-labeled glycerophospholipids from the luminal to the exposed face of proteoliposomes as assessed by both dithionite sensitivity and BSA-mediated lipid removal. The lipid redistribution is constitutive, ATP-independent and increases with increasing concentrations of reconstituted protein, but critically occurs without exposure of other soluble luminal contents as measured in a parallel leakage assay. Thus, by each of these measures, TMEM41B and VMP1 are lipid scramblases.

The Yang group also demonstrated that these proteins contribute to lipid distribution throughout the cell (Li et al., 2021). They expressed GFP-tagged sensors of different lipid populations in wildtype cells and cells depleted for TMEM41B and/or VMP1 and discovered that depletion of either scramblase leads to a mis-sorting of both phosphatidylserine (PS) and cholesterol. PS normally accumulates on the cytoplasmic face of the plasma membrane and endolysosomal compartments, but can be found on the lumenal face of the ER and early Golgi (e.g. Fairn et al., 2011; Holthuis and Menon, 2014; Hankins et al., 2015; note there is some cell-type dependence to this distribution: Tsuji et al., 2019). However, in cells depleted for TMEM41B and/or VMP1, they find that the luminal PS pool is missing, and instead these cells accumulate about twice as much cytoplasm-facing PS. In addition, these cells redistribute cholesterol from internal organelles to the plasma membrane which, as the authors note, is consistent with other work connecting PS levels to cholesterol trafficking (Maekawa and Fairn, 2015; Ercan et al., 2021). Likewise, Huang et al. (2021) introduced click-chemistry reactive choline headgroups into phosphatidylcholine (PC) to track PC on each leaflet. They discovered a similar loss of PC from the lumenal but not cytoplasmic face of the ER when TMEM41B is depleted. These results demonstrate that the VTT family scramblases play a major role in balancing the two leaflets in the biogenic ER membrane.

The identity of the scramblases moving newly synthesized lipids off the cytoplasmic face of the ER has been a long-standing question (Holthuis and Menon, 2014). Recently, several groups have shown that TMEM16K is a calcium-dependent ER-scramblase (Bushell et al., 2019; Tsuji et al., 2019), and there may still be other scramblases necessary to move specific subpopulations of lipid (Verchere et al., 2021). We suggest below that scramblase activity is required locally, and thus it may be advantageous to recruit specific scrambling proteins to different ER membrane events. However, the apparent complete loss of PS from luminal membranes when TMEM41B and VMP1 are missing suggests the intriguing possibility that these two scramblases may also play a fundamental and constitutive role in ER lipid homeostasis. This idea is consistent with new discoveries from the Chen lab, showing that the absence of these proteins promotes a new type of stress signal originated from imbalanced ER membrane leaflets, which are interpreted as a trigger of a new lipid-homeostasis sensing pathway, connecting in part to the SREBP response (Huang et al., 2021).

TMEM41B and VMP1 in Lipid Droplet and Apolipoprotein Production on the ER

Biogenesis of both lipid droplets (on the cytoplasmic face of the ER) and apolipoproteins (on the luminal face of the ER) depends upon ER-derived phospholipids to coat their growing neutral lipid cores. Genetic depletion of either TMEM41B or VMP1 drives the accumulation of oversized lipid droplets (Tabara and Escalante, 2016; Moretti et al., 2018; Morita et al., 2018) and incompletely formed or missing apolipoproteins with a concomitant loss of apolipoprotein-dependent lipid secretion (Morishita et al., 2019; Huang et al., 2021). The mechanism(s) through which TMEM41B or VMP1 regulate each of these events has not been understood. One possibility is that these events are a result of the global changes in lipid homeostasis detected when each is depleted in the cell (Huang et al., 2021; Li et al., 2021). For example, in vitro reconstitution of LD biogenesis suggests that both the levels of local cholesterol and the structure of local lipid asymmetry across the bilayer are key regulators in LD budding (Chorlay et al., 2019), each of which is now established to be disrupted in the TMEM41B/VMP1 depleted cells.

Alternatively, there are indications that TMEM41B and VMP1 in fact act locally, and perhaps directly engage the machinery responsible for membrane remodeling events on the ER. For example, in the case of LD biogenesis several groups have shown a colocalization of VMP1 with LD budding sites (Tabara and Escalante, 2016; Zhao et al., 2017). How it is localized is not yet known, although Yang and colleagues ruled out direct interactions between VMP1 or TMEM41B with the LD biogenesis protein Seipin (Li et al., 2021). A similar local role in lipoprotein production is now suggested by the work from Huang et al. (2021). The biogenesis of lipoproteins starts with the co-translational insertion of the major structural protein apolipoprotein B (ApoB) into the ER lumen, where ApoB is stabilized by the loading of lipids via the microsomal triglyceride transfer proteins (MTP). Through combinations of proteomics, co-immunoprecipitations and localization of endogenous tagged proteins, Huang et al. (2021) discovered that TMEM41B directly interacts with both ApoB and the apolipoprotein carrier protein SURF4, concentrated at the so-called ER exit sites. These data imply a possible protein complex-mediated coordination of local lipid availability, apolipoprotein production and lipoprotein trafficking to secretion sites on the ER. They also noted that the depletion of TMEM41B presents a more severe phenotype than depletion of VMP1, consistent with other recent reports that these two proteins are functionally similar but not perfectly redundant (e.g. Morita et al., 2018; Shoemaker et al., 2019) and perhaps indicative of the specific need for TMEM41B-apolipoprotein interactions during biogenesis.

TMEM41B and VMP1 as Pieces of a Cohesive Lipid-Transport System Functioning at Contact Sites

New discoveries by the Melia and Reinisch labs (Ghanbarpour et al., 2021) indicate that TMEM41B and VMP1 also act locally in autophagosome biogenesis, as part of a complex lipid transport system at ER-autophagosome contact sites that moves lipids from the ER to expand the autophagosome. They found a direct interaction between TMEM41B or VMP1 and ATG2, a club-shaped structure proposed to function as bridge that allows for bulk lipid flow between compartments (Valverde et al., 2019). While this interaction requires the N-terminal end of the ATG2 “club” (Ghanbarpour et al., 2021), another portion of ATG2 interacts directly with a second scramblase, ATG9, in Golgi derived vesicles that initiate autophagosome formation (Maeda et al., 2020; Matoba et al., 2020; Ghanbarpour et al., 2021). Thus, they proposed that TMEM41B/VMP1, ATG2, and ATG9 form a lipid transfer complex (Ghanbarpour et al., 2021) analogous to those observed in prokaryotes, such as the lipopolysaccharide transport system that moves lipids between the inner and outer membranes of Gram-negative bacteria (Okuda et al., 2016) (Figure 1). Bacterial lipopolysaccharide transport couples a lipid transport bridge with integral membrane proteins in both the lipid donor and acceptor compartments. These proteins re-equilibrate the membrane leaflets as lipids are removed or added and perhaps help in partitioning lipids between the transport protein and membranes, steps that are energetically costly and rate limiting (Reinisch and Prinz, 2021). During autophagosome formation, TMEM41B/VMP1 likely channel lipids onto ATG2 while also re-equilibrating the leaflets of the ER as lipids are extracted, then the lipids flow along ATG2 to ATG9 in the nascent autophagosome. ATG9 could help to insert arriving lipids into the autophagosome membrane and likely re-equilibrates the cytosolic and luminal leaflets to allow for membrane expansion (Maeda et al., 2020; Matoba et al., 2020; Ghanbarpour et al., 2021).

OPEN IN VIEWER

Figure 1.

TMEM41B and VMP1 Are Glycerolipid Scramblases (Ghanbarpour et al., 2021; Li et al., 2021) Important for Cellular Lipid Distribution From the ER. They can also act locally as components of lipid transport machinery, as shown here cooperating with the lipid transport protein ATG2 and a scramblase in the nascent autophagosome, ATG9, in supplying lipids for autophagosome biogenesis at ER-autophagosome membrane contact sites. They are also components of a protein assembly that facilitates maturation of lipoproteins in the ER (Huang et al., 2021).

Autophagosome biogenesis has evolved into a prominent model system in which to study de novo growth of organelles, especially those not connected to vesicular trafficking pathways. Importantly, ATG2 is structurally and functionally similar to VPS13-proteins, which are involved in various membrane biogenesis events, including prospore formation in yeast (Park and Neiman, 2012), and mitochondrial maintenance (Baldwin et al., 2021; Guillen-Samander et al., 2021) and peroxisome (Baldwin et al., 2021) and acrosome (Da Costa et al., 2020) formation in metazoa. Thus, we propose that VPS13-proteins are like ATG2 in cooperating with scramblases in bulk lipid transport. Indeed, human VPS13A has been reported to interact directly with a putative scramblase XK (Park and Neiman, 2020), and yeast Vps13 interacts directly with an integral membrane protein in the outer mitochondrial membrane ( Mcp1: John Peter et al., 2017; Bean et al., 2018) which has scrambling activity (Reinisch lab, unpublished). In humans, VPS13’s may transport lipids from the ER as VPS13A, -C, and -D all localize to contact sites with the ER (Kumar et al., 2018; Baldwin et al., 2021; Guillen-Samander et al., 2021), but no ER scramblase has yet been identified as an interaction partner. Because VPS13’s and ATG2 share sequences at their N-terminal ends (chorein-N motif, Munoz-Braceras et al., 2015) one intriguing possibility is that the human VPS13’s might also interact with TMEM41B or VMP1, which are already known to have such broad roles in membrane dynamics, in coordinating bulk lipid transfer.